Clinical Trials

Accrual Status
Limit to SWOG Trials

1028 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Closed S0307A ANCILLARY: S0307 Companion Study 10/1/2008 2/1/2010 0%
    Closed S0308 Reduction of Skeletal Events in Advanced Breast Cancer 5/15/2006 6/8/2006 0%
    Closed S0309 Myeloma Repository 11/15/2003
    Closed S0310 CG8123 (GVAX) in selected Stage IIIB and IV BAC 3/1/2004 8/19/2005 16%
    Closed S0312 Advanced Renal 12/1/2004 8/15/2005 100% Published
    Closed S0313 NON-HODGKIN'S: CHOP + IF RT followed by Yttrium-90 Ibritumomab Tiuxetan 2/1/2004 12/15/2008 77% Published
    Closed S0316 Barriers to Accrual 8/1/2004 6/15/2008 97% Published
    Closed S0317 Advanced Renal 5/1/2003 12/15/2005 100% Published
    Closed S0322 ZD1839/75 yrs or older and in a cohort of 50 yrs or older/Adv. H&N NSCLC 8/15/2003 2/15/2005 25%
    Closed S0325 Phase IIb Imatinib or Dasatinib for Untreated Chronic CML 8/15/2004 2/28/2009 100% Published
    Closed S0327 PS-341/Platinum-treated/Extensive SCLC 9/1/2003 9/15/2004 75% Published
    Closed S0329 Recurrent of Metastatic Squamous Cell Carcinoma of the Head and Neck 1/1/2005 1/1/2007 100% Published
    Closed S0330 Malignant Peripheral Nerve Sheath Tumors 12/15/2003 1/15/2006 60% Published
    Closed S0331 STI-571/Imatinib/Merkel Cell Melanoma 10/1/2003 3/1/2007 62% Published
    Closed S0333 Phase II Double Induction for Newly Diagnosed Non-L3 ALL 4/15/2005 100%
    Closed S0334 Cytogenetics and FISH in Multiple Myeloma 9/1/2005 6/15/2007
    Closed S0336 COLORECTAL 4/15/2004 9/1/2005 70% Published
    Closed S0337 Superficial Bladder, Post-TURBT Gemcitabine vs Saline, Ph III 7/15/2007 8/15/2012 100%
    Closed S0338 ADVANCED: Imatinib Mesylate Plus Capecitabine for Stage IV Breast Cancer 6/15/2004 12/15/2005 39% Published
    Closed S0339 Gemcitabine/Carboplatin & PS-341/NSCLC 1/15/2004 10/1/2004 100% Published
    Scroll Table